OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: The University of Texas Southwestern Medical Center at Dallas

3 Projects | 2 Researchers | $822,000 Invested

2025

The University of Texas Southwestern Medical Center at Dallas

Marc Diamond, MD

AAV-mediated clearance of tau aggregates in vivo

  • Funding Amount: $600,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Tau
  • Status: Active

2009

The University of Texas Southwestern Medical Center at Dallas

Ilya Bezprozvanny, PhD

Ryanodine receptor type 2 as a target for AD

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2008

The University of Texas Southwestern Medical Center at Dallas

Ilya Bezprozvanny, PhD

Ryanodine receptor as target for AD

  • Funding Amount: $122,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed